Doxorubicin (DOXO), an anthracycline antibiotic, is a potent anticancer agent with severe toxic side-effects that have been attributed to its ability to generate free radicals (ROS), particularly in mitochondria. In this study, a prokaryotic organism, Salmonella typhimurium, was used to evaluate the effect of the drug on ROS-scavenging enzymes, catalase (CAT) and superoxide dismutase (SOD) activity, and on cell growth and viability. Increasing DOXO concentrations in the culture medium led to increasingly prolonged lag period, reduced growth rate and cell viability, and inhibition of SOD and CAT activity. SOD activity dropped to 66% of the control value in cells grown with 1 µg/ml DOXO and to 34% and 28% in cells grown with 150 and 300 µg/ml DOXO. CAT activity decreased progressively from 93% in 1 µg/ml DOXO to 30% in 150 µg/ml DOXO and was undetectable in 300 µg/ml. Growth in the presence of DOXO led to alterations in cytokinesis, as seen upon examination of cells under fluorescence microscope.